Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Fracta Therapeutics AS
AS
Active
Org 926960288
Gaustadalléen 21, 0349
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 5 years old
4 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Fracta Therapeutics AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
NOK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
Revenue
225
0
0
0
Staff expenses
−20
−1
−0
−0
EBITDA
5
−25
−17
−6
Depreciation & amort.
−0
−0
−0
−0
EBIT
5
−25
−17
−6
Net financials
−0
0
0
0
Profit before tax
4
−25
−17
−6
Tax
−0
−0
−0
−0
Net profit
4
−25
−17
−6
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
Total assets
16
4
1
18
Equity
14
−24
1
18
Long-term debt
0
28
0
0
Short-term debt
2
0
0
0
Total debt
2
28
0
0
Financial ratios
5-year trend
EBITDA margin
2,1 %
This company
15,8 %
Market median
This company
Market median
87% below market
2021
2024
Equity ratio
87,3 %
This company
38,2 %
Market median
This company
Market median
129% above market
2021
2024
Return on equity
32,7 %
This company
18,4 %
Market median
This company
Market median
78% above market
2021
2024
Net profit margin
2,0 %
This company
8,1 %
Market median
This company
Market median
75% below market
2021
2024
Asset turnover
14,26×
This company
1,12×
Market median
This company
Market median
>999% above market
2021
2024
Debt / equity
0,15×
This company
0,62×
Market median
This company
Market median
76% below market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-03-17 – 2021-12-31
View
PDF
More on Fracta Therapeutics AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
